Tag - drug development

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

Cloud for AI/ML & Modern Data Science

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Novel Genetic Priority Score (GPS) Unveiled to Enhance Target Prioritization in Drug Development

Deepcell Aims to Create a Single Cell Morpholome Platform

HiberCell Expands Translational Oncology Toolbox by Acquiring Genuity Science, Inc.

GATC Health and Liquid Biosciences Partner to Improve Drug Development & Precision Medicine Research

Large-Scale Study Shows Guardant360 Liquid Biopsy Accelerates Clinical Trial Enrollment Compared to Tissue Biopsy

Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation

Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics

Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”

The JP Morgan Healthcare Conference from Afar

Welcome to the enlightenbio blog!

Copyright © 2026. enlighenbio LLC. All rights reserved.